Steroid tape to treat overgranulating peritoneal dialysis catheter exit sites

Not Applicable

Completed

• Conditions: Topic: Renal disorders; Subtopic: Renal disorders; Disease: All Renal disorders; Urological and Genital Diseases

• Registration Number: ISRCTN27017084
• Lead Sponsor: niversity Hospital Birmingham NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-01-08
• Study Completion: 2016-08-30
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Subject has been established on Peritoneal Dialysis for > 3 months
2. Subject has an over-granulating exit site judged to require treatment according to standard
3. If patient has exit site infection, they must currently be treated with antibiotics and the site must be clinically improving.
4. Subject is > 18 years of age
5. Subject is able to give informed consent

Exclusion Criteria

1. Subject has had peritonitis treated in the previous month
2. Subject has been treated with silver nitrate or topical steroids in the previous 2 weeks
3. Subject is receiving oral steroids
4. Patient is unable to give informed consent
5. Patient is participating in a clinical trial of an intervention relating to PD catheters
6. Subject is pregnant or unwilling to use an effective method of contraception during the course of the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete response rate in over-granulation severity; Timepoint(s): 14 days